New study aims to protect older breast cancer patients from hidden drug risks
NCT ID NCT07273357
First seen Jan 04, 2026 · Last updated May 22, 2026 · Updated 27 times
Summary
This study follows 200 breast cancer patients aged 70 and older who are starting a combination of CDK4/6 inhibitors and hormone therapy after surgery. Researchers want to see if simple geriatric screening tests can predict who will have side effects or a drop in quality of life. The goal is to help doctors tailor treatment for older adults, who are often left out of drug trials.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GERIATRIC ASSESSMENT are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Department of Oncology
Gävle, Sweden
Contact Email: •••••@•••••
-
Department of Oncology
Gothenburg, Sweden
Contact Email: •••••@•••••
-
Department of Oncology
Jönköping, 55312, Sweden
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Department of Oncology
Kalmar, Sweden
Contact Email: •••••@•••••
-
Department of Oncology
Linköping, Sweden
Contact Email: •••••@•••••
-
Department of Oncology
Örebro, Sweden
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.